Literature DB >> 1086343

The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain.

A Carlsson, W Kehr, M Lindqvist.   

Abstract

The influence of varying brain levels of dopamine, noradrenaline and 5-HT on their respective synthesis rates has been investigated. The first step in monoamine synthesis was studied in vivo by measuring the accumulation of dopa and 5-hydroxytryptophan after inhibition of the aromatic L-amino acid decarboxylase. Variations in monoamine levels were obtained by combined treatment with inhibitors of the decarboxylase (NSD 1015 or Ro 4-4602) and of monoamine oxidase (pargyline). An increase in monoamine levels by pargyline was found to inhibit the synthesis of dopamine, noradrenaline and 5-HT. Conversely, a decrease in monoamine levels induced by the decarboxylase inhibitor Ro 4-4602 appeared to stimulate dopamine and noradrenaline synthesis but had no effect on 5-HT synthesis. The influence of varying levels of dopamine and noradrenaline on the synthesis of these amines could still be demonstrated after blockade of dopamine receptos and of alpha-adrenergic (noradrenaline) receptors by haloperidol, suggesting that the mechanism involved in this feedback control is mediated via end-product inhibition of tyrosine hydroxylase. On the other hand, the stimulating influence of haloperidol on the synthesis of catecholamines does not seem to be directly related to changes in catecholamine levels. It is concluded that the short-term control of catecholamine synthesis presumably involves two independent feedback mechanisms, one intraneuronal mechanism operating via end-product inhibition, and one synaptic mechanism mediated via dopamine and noradrenaline receptors, respectively. Both pre- and postsynaptic receptors may be involved in the latter mechanism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086343     DOI: 10.1007/bf01248762

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  16 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

Review 2.  Simple neuronal models to estimate turnover rate of noradrenergic transmitters in vivo.

Authors:  E Costa
Journal:  Adv Biochem Psychopharmacol       Date:  1970

3.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

4.  Turnover rates of serotonin and norepinephrine in brain of normal and parglyline-treated rats.

Authors:  R C Lin; N H Neff; S H Ngai; E Costa
Journal:  Life Sci       Date:  1969-10-01       Impact factor: 5.037

5.  Further studies on tryptophan hydroxylase in rat brainstem and beef pineal.

Authors:  E Jequier; D S Robinson; W Lovenberg; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1969-05       Impact factor: 5.858

6.  In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain.

Authors:  A Carlsson; M Lindqvist
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

7.  Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo.

Authors:  A Carlsson; M Lindqvist
Journal:  J Pharm Pharmacol       Date:  1973-06       Impact factor: 3.765

8.  Distribution of dopamine in the rat cerebral cortex.

Authors:  W Kehr; M Lindqvist; A Carlsson
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

9.  A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors:  W Kehr; A Carlsson; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

10.  Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.

Authors:  N E Andén; H Corrodi; K Fuxe; T Hökfelt
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

View more
  19 in total

1.  Hallucinogen-induced rotational behavior in rats.

Authors:  L N Fleisher; S D Glick
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

2.  Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Authors:  Jennifer C Felger; Jiyoung Mun; Heather L Kimmel; Jonathon A Nye; Daniel F Drake; Carla R Hernandez; Amanda A Freeman; David B Rye; Mark M Goodman; Leonard L Howell; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2013-05-09       Impact factor: 7.853

3.  Comparison of diurnal and nocturnal rates of 5-hydroxytryptamine turnover in the rat mediobasal hypothalamus.

Authors:  T S King; S Steinlechner; R W Steger
Journal:  Experientia       Date:  1985-03-15

4.  Effects of multiple pretreatment with apomorphine and amphetamine on amphetamine-induced locomotor activity and its inhibition by apomorphine.

Authors:  W H Riffee; R E Wilcox
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Brain serotonin and 5-hydroxyindoleacetic acid concentrations and serotonin synthesis following tetrahydro-beta-carboline administration in mice.

Authors:  N S Buckholtz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

6.  Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease.

Authors:  David S Goldstein; Courtney S Holmes; Stephen G Kaler
Journal:  Neurochem Res       Date:  2009-02-21       Impact factor: 3.996

7.  Postnatal manganese exposure does not alter dopamine autoreceptor sensitivity in adult and adolescent male rats.

Authors:  Sanders A McDougall; Alena Mohd-Yusof; Graham J Kaplan; Zuhair I Abdulla; Ryan J Lee; Cynthia A Crawford
Journal:  Eur J Pharmacol       Date:  2013-02-28       Impact factor: 4.432

8.  Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

Authors:  David S Goldstein; Yunden Jinsmaa; Patti Sullivan; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

9.  Day-night differences in estimated rates of 5-hydroxytryptamine turnover in the rat pineal gland.

Authors:  T S King; R W Steger; S Steinlechner; R J Reiter
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

10.  Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain.

Authors:  Gerard Honig; Minke E Jongsma; Marieke C G van der Hart; Laurence H Tecott
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.